Who Is Thrombogenic: The Scaffold or the Doctor? Back to the Future!

被引:29
作者
Colombo, Antonio [1 ,2 ]
Ruparelia, Neil [1 ,3 ]
机构
[1] Ist Sci San Raffaele, Dept Intervent Cardiol, I-20145 Milan, Italy
[2] EMO GV Ctr Cuore Columbus, I-20145 Milan, Italy
[3] Univ London Imperial Coll Sci Technol & Med, Dept Cardiol, London, England
关键词
bioresorbable scaffold; drug-eluting stent(s); thrombosis; STENT THROMBOSIS; ELUTING STENTS; REGISTRY; OUTCOMES;
D O I
10.1016/j.jcin.2015.09.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:25 / 27
页数:3
相关论文
共 14 条
[1]  
[Anonymous], 1995, CIRCULATION
[2]   Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry [J].
Capodanno, Davide ;
Gori, Tommaso ;
Nef, Holger ;
Latib, Azeem ;
Mehilli, Julinda ;
Lesiak, Maciej ;
Caramanno, Giuseppe ;
Naber, Christoph ;
Di Mario, Carlo ;
Colombo, Antonio ;
Capranzano, Piera ;
Wiebe, Jens ;
Araszkiewicz, Aleksander ;
Geraci, Salvatore ;
Pyxaras, Stelios ;
Mattesini, Alessio ;
Naganuma, Toru ;
Muenzel, Thomas ;
Tamburino, Corrado .
EUROINTERVENTION, 2015, 10 (10) :1144-1153
[3]   Impact of Strut Width in Periprocedural Myocardial Infarction A Propensity-Matched Comparison Between Bioresorbable Scaffolds and the First-Generation Sirolimus-Eluting Stent [J].
Kawamoto, Hiroyoshi ;
Panoulas, Vasileios F. ;
Sato, Katsumasa ;
Miyazaki, Tadashi ;
Naganuma, Toru ;
Sticchi, Alessandro ;
Figini, Filippo ;
Latib, Azeem ;
Chieffo, Alaide ;
Carlino, Mauro ;
Montorfano, Matteo ;
Colombo, Antonio .
JACC-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (07) :900-909
[4]   Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial [J].
Kedhi, Elvin ;
Joesoef, Kaiyum Sheik ;
McFadden, Eugene ;
Wassing, Jochem ;
van Mieghem, Carlos ;
Goedhart, Dick ;
Smits, Pieter Cornelis .
LANCET, 2010, 375 (9710) :201-209
[5]  
Kimura K, 2015, EUR SOC CARD C AUG 2
[6]   How to Minimize Stent Thrombosis [J].
Kirtane, Ajay J. ;
Stone, Gregg W. .
CIRCULATION, 2011, 124 (11) :1283-1287
[7]   Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings [J].
Kolandaivelu, Kumaran ;
Swaminathan, Rajesh ;
Gibson, William J. ;
Kolachalama, Vijaya B. ;
Nguyen-Ehrenreich, Kim-Lien ;
Giddings, Virginia L. ;
Coleman, Leslie ;
Wong, Gee K. ;
Edelman, Elazer R. .
CIRCULATION, 2011, 123 (13) :1400-1409
[8]   Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry [J].
Kraak, Robin P. ;
Hassell, Mariella E. C. J. ;
Grundeken, Maik J. ;
Koch, Karel T. ;
Henriques, Jose P. S. ;
Piek, Jan J. ;
Baan, Jan, Jr. ;
Vis, Marije M. ;
Arkenbout, E. Karin ;
Tijssen, Jan G. P. ;
de Winter, Robbert J. ;
Wykrzykowska, Joanna J. .
EuroIntervention, 2015, 10 (10) :1160-1168
[9]   Scaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold [J].
Lipinski, Michael J. ;
Escarcega, Ricardo O. ;
Baker, Nevin C. ;
Benn, Hadiya A. ;
Gaglia, Michael A., Jr. ;
Torguson, Rebecca ;
Waksman, Ron .
JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (01) :12-24
[10]   A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents [J].
Schomig, A ;
Neumann, FJ ;
Kastrati, A ;
Schuhlen, H ;
Blasini, R ;
Hadamitzky, M ;
Walter, H ;
ZitzmannRoth, EM ;
Richardt, G ;
Alt, E ;
Schmitt, C ;
Ulm, K .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (17) :1084-1089